UPDATE 1-Zoll Medical Q2 profit beats Wall Street view

* Q2 EPS $0.17 vs est $0.13

* Q2 rev $107.1 mln vs est $105 mln

* Sees full-year earnings in mid-80 cents range

* Maintains view for H2 of 2010

April 29 (BestGrowthStock) – Zoll Medical Corp (ZOLL.O: ), a maker of
cardiac resuscitation products, posted a better-than-expected
quarterly profit, driven by growth in its LifeVest business and
inclusion of its temperature management business.

The company expects full-year earnings to be in the mid-80
cents range, and said it remained cautiously optimistic on the
recovery of its core defibrillator business.

Zoll said North American hospital defibrillator revenues
grew from the comparable quarter last year, although North
American hospital and emergency medical services (EMS)
environments continued to face spending constraints.

Net income for the quarter was $3.6 million or 17 cents a
share, compared to $1.8 million, or 8 cents a share, a year
ago.

Revenue for the quarter was up 15 percent to $107.1
million.

Analysts on average expected the company to earn 13 cents a
share, on revenue of $105 million, according to Thomson Reuters
I/B/E/S.

The company said it was not changing its expectations for
the second half of 2010.

Shares of Zoll closed at $27.91 Wednesday on Nasdaq.

Investment Tools

(Reporting by Krishnakali Sengupta in Bangalore; Editing by
Roshni Menon)

UPDATE 1-Zoll Medical Q2 profit beats Wall Street view